Clinigen Unveils Educational Program for Rare Disease Patients and Organizations
The program to facilitate engagement between HCPs, industry, and regulatory bodies.
Clinigen, a pharmaceutical services company, has launched NaviGATE, a UK-based pilot educational program for rare disease patient advocates and organizations. The program was co-created by Clinigen with the involvement of representatives of the rare community and patient advocacy groups; it aims to offer navigational support and tools to better engage with health care providers (HCPs),industry, and regulatory bodies. The overall goal is to facilitate greater participation in rare disease research and development, and to enable increased access to medicines for more patients.
It starts with a research questionnaire provided to the rare disease community that aims to provide an understanding of the needs of this community and the gaps that should be addressed. Clinigen’s intention is to use the learnings from this questionnaire to inform the creation of an educational training program.
“At Clinigen, we are committed to incorporating the voice of the patient and to working in partnership with patient advocacy groups,” says Lorna Pender, Clinigen’s global patient engagement lead. “Patients with rare diseases often struggle to understand how to cut through the complexity of this industry and make their voices heard among decision makers. This unique initiative will help us co-design a program which should help this community use its voice in an informed way to influence industry, healthcare providers, and regulators.”
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
